Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)
China
· Delayed Price · Currency is CNY 5.01
-0.07 (-1.38%)
Apr 30, 2026, 11:05 AM CST
SHE:002424 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 6,934 | 5,938 | 5,255 | 11,236 | 11,404 | 10,622 | Upgrade
|
| Market Cap Growth | 16.51% | 12.99% | -53.23% | -1.47% | 7.37% | -3.87% | Upgrade
|
| Enterprise Value | 7,904 | 6,965 | 6,933 | 12,721 | 12,731 | 12,179 | Upgrade
|
| Last Close Price | 5.08 | 4.35 | 3.85 | 8.11 | 8.16 | 7.60 | Upgrade
|
| PE Ratio | - | - | 156.31 | - | 82.36 | 89.65 | Upgrade
|
| Forward PE | - | 17.71 | 17.71 | 17.71 | 17.71 | 17.71 | Upgrade
|
| PS Ratio | 2.36 | 1.95 | 1.37 | 2.64 | 3.22 | 3.41 | Upgrade
|
| PB Ratio | 2.17 | 1.87 | 1.64 | 3.42 | 2.85 | 2.74 | Upgrade
|
| P/TBV Ratio | 2.33 | 2.02 | 1.78 | 3.69 | 3.03 | 2.92 | Upgrade
|
| P/FCF Ratio | 14.76 | 9.52 | - | 519.03 | 26.30 | - | Upgrade
|
| P/OCF Ratio | 11.64 | 7.93 | 582.59 | 89.34 | 22.71 | 32.69 | Upgrade
|
| EV/Sales Ratio | 2.70 | 2.29 | 1.81 | 2.98 | 3.60 | 3.92 | Upgrade
|
| EV/EBITDA Ratio | 22.66 | 20.29 | 55.88 | - | 38.96 | 38.29 | Upgrade
|
| EV/EBIT Ratio | 35.52 | 30.66 | 353.32 | - | 56.98 | 54.65 | Upgrade
|
| EV/FCF Ratio | 16.83 | 11.17 | - | 587.59 | 29.35 | - | Upgrade
|
| Debt / Equity Ratio | 0.35 | 0.39 | 0.56 | 0.51 | 0.39 | 0.44 | Upgrade
|
| Debt / EBITDA Ratio | 3.24 | 3.51 | 13.30 | - | 4.62 | 5.20 | Upgrade
|
| Debt / FCF Ratio | 2.41 | 1.97 | - | 77.89 | 3.61 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.30 | 0.28 | 0.44 | 0.39 | 0.24 | 0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.78 | 2.55 | 11.29 | -4.26 | 2.95 | 3.93 | Upgrade
|
| Net Debt / FCF Ratio | 2.03 | 1.40 | -42.44 | 58.59 | 2.22 | -12.39 | Upgrade
|
| Asset Turnover | 0.45 | 0.46 | 0.53 | 0.60 | 0.53 | 0.46 | Upgrade
|
| Inventory Turnover | 1.83 | 1.81 | 1.46 | 1.98 | 1.76 | 1.58 | Upgrade
|
| Quick Ratio | 0.67 | 0.71 | 0.64 | 0.73 | 1.07 | 1.09 | Upgrade
|
| Current Ratio | 0.95 | 0.97 | 0.96 | 1.06 | 1.38 | 1.45 | Upgrade
|
| Return on Equity (ROE) | -3.12% | -3.24% | 1.14% | -11.33% | 3.46% | 2.81% | Upgrade
|
| Return on Assets (ROA) | 2.14% | 2.13% | 0.17% | -3.52% | 2.09% | 2.06% | Upgrade
|
| Return on Invested Capital (ROIC) | -13.49% | -13.39% | 0.24% | -8.46% | 3.79% | 3.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.80% | 6.70% | 0.60% | -11.20% | 5.40% | 5.50% | Upgrade
|
| Earnings Yield | -1.45% | -1.76% | 0.64% | -3.69% | 1.21% | 1.11% | Upgrade
|
| FCF Yield | 6.77% | 10.50% | -0.63% | 0.19% | 3.80% | -0.95% | Upgrade
|
| Payout Ratio | - | - | 241.94% | - | 62.50% | 84.56% | Upgrade
|
| Buyback Yield / Dilution | 18.39% | 22.40% | -21.67% | 0.22% | 6.50% | -6.92% | Upgrade
|
| Total Shareholder Return | 18.39% | 22.40% | -21.67% | 0.22% | 6.50% | -6.92% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.